ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
UC Davis Comprehensive Cancer Center at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
UC Davis Comprehensive Cancer Center takes part in 3 sessions at ESMO 2026 in Madrid. Its work spans lung cancer biomarkers, treatment resistance and patient-reported outcomes. It examines genetic changes in lung tumors and resistance to firmonertinib, alongside outcomes in small cell lung cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
UC Davis Comprehensive Cancer Center Sacramento, CA | |
Comprehensive cancer center of the University of California, Davis, providing cancer care in Sacramento, CA. | Satellite Sun Oct 25 18:50–19:10 How Do Patient-Reported Outcomes Shape Clinical Decisions? Nursing & supportive care Poster Mon Oct 26 12:00–12:45 Genomic and biomarker landscape of MTAP loss/KRAS G12D mutant vs. MTAP loss/KRAS non-mutated advanced NSCLC Lung & thoracic cancersBiomarkers & precision oncology Poster Mon Oct 26 12:00–12:45 Abstract Mon Oct 26 14:55–15:05 |
Find decision makers at UC Davis Comprehensive Cancer Center
Tell us what you sell and we’ll find the people at UC Davis Comprehensive Cancer Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction